CIK: 0001683689 · Show all filings
Period: Q2 2022 (← Previous) (Next →)
Filing Date: Aug 16, 2022
Total Value ($000): $142,357 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Horizon Therapeutics Public Limited Company | 544,043 | $43,393 | 30.5% | $68.27 | — | SHS | G46188101 |
| IEFA | ISHARES TR | 390,722 | $22,994 | 16.2% | $72.87 | — | CORE MSCI EAFE | 46432F842 |
| FIVN | Five9, Inc. | 174,478 | $15,902 | 11.2% | $120.22 | -15.9% | COM | 338307101 |
| — | JAMF HOLDING CORP | 621,243 | $15,388 | 10.8% | $35.90 | — | COM | 47074L105 |
| IEMG | ISHARES TR | 304,745 | $14,951 | 10.5% | $64.35 | — | CORE MSCI EMKT | 46434G103 |
| VCEL | Vericel Corporation | 552,973 | $13,924 | 9.8% | $15.89 | +85.8% | COM | 92346J108 |
| NEO | NeoGenomics Inc. | 1,615,513 | $13,166 | 9.2% | $23.81 | -59.9% | COM NEW | 64049M209 |
| MITK | MITEK SYS INC | 251,055 | $2,320 | 1.6% | $18.39 | -42.1% | COM NEW | 606710200 |
| ISTB | ISHARES TR | 2,228 | $106 | 0.1% | $51.59 | — | CORE 1 5 YR USD | 46432F859 |
| IVV | ISHARES TR | 234 | $89 | 0.1% | $335.62 | — | CORE S&P500 ETF | 464287200 |
| IAGG | ISHARES TR | 862 | $43 | 0.0% | $56.04 | — | CORE INTL AGGR | 46435G672 |
| IMTB | ISHARES TR | 834 | $37 | 0.0% | $52.19 | — | CR 5 10 YR ETF | 46435G417 |
| IJH | ISHARES TR | 122 | $28 | 0.0% | $183.67 | — | CORE S&P MCP ETF | 464287507 |
| IJR | ISHARES TR | 169 | $16 | 0.0% | $72.46 | — | CORE S&P SCP ETF | 464287804 |